Initial combination therapy with adalimumab and methotrexate leads to better long-term inhibition of radiographic progression in earl RA: 5-year results of the PREMIER trial

被引：0
|
作者：
van der Heijt, Desiree [1 ]
Landewe, Robert [1 ]
Shap, John T. [2 ]
Keystone, Edward C. [3 ]
Patra, Kaushik [4 ]
Perez, John L. [4 ]
Pangan, Aileen L. [5 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Univ Washington, Sch Med, Seattle, WA USA
[3] Univ Toronto, Toronto, ON, Canada
[4] Abbott Labs, Parsippany, NJ USA
[5] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S535 / S535
页数：1
相关论文
共 50 条
  • [1] Better Long-term Inhibition of Radiographic Progression in Early RA with Adalimumab and Methotrexate Initial Combination Therapy: 5-Year Results of The PREMIER Trial
    Keystone, E. C.
    van der Heijde, D.
    Landewe, R.
    Patra, K.
    Perez, J. L.
    Pangan, A. L.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2573 - 2574
  • [2] Sustained Clinical Remission and Response for Early RA Patients with Adalimumab and Methotrexate Initial Combination Therapy: 5-Year Results of the PREMIER Trial
    Keystone, E. C.
    Breedveld, F. C.
    Kavanaugh, A.
    van Riel, P.
    Patra, K.
    Pangan, A.
    Perez, J. L.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2598 - 2598
  • [3] Disease Activity, Physical Function, and Radiographic Progression After Longterm Therapy with Adalimumab Plus Methotrexate: 5-Year Results of PREMIER
    van der Heijde, Desiree
    Breedveld, Ferdinand C.
    Kavanaugh, Arthur
    Keystone, Edward C.
    Landewe, Robert
    Patra, Kaushik
    Pangan, Aileen L.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (11) : 2237 - 2246
  • [4] TWO YEARS OF ADALIMUMAB AND METHOTREXATE COMBINATION THERAPY ASSOCIATED WITH GREATER INHIBITION OF RADIOGRAPHIC PROGRESSION AFTER 5 YEARS IN PATIENTS WITH EARLY RA
    Pangan, A. L.
    van der Heijde, D.
    Landewe, R.
    Keystone, E. C.
    Patra, K.
    Perez, J. L.
    RHEUMATOLOGY, 2009, 48 : I84 - I85
  • [5] Long-Term Impact of Delaying Combination Therapy With Adalimumab Plus Methotrexate By 2 Years in Patients With Early Rheumatoid Arthritis: Final 10-Year Results of the Premier Trial
    Keystone, Edward C.
    Breedveld, Ferdinand C.
    van der Heijde, Desiree
    Landewe, Robert
    Florentinus, Stefan
    Arulmani, Udayasankar
    Liu, Shufang
    Kupper, Hartmut
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S595 - S595
  • [6] LONG-TERM IMPACT OF DELAYING COMBINATION THERAPY WITH ADALIMUMAB PLUS METHOTREXATE BY 2 YEARS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: FINAL 10-YEAR RESULTS OF THE PREMIER TRIAL
    Keystone, E. C.
    Breedveld, F. C.
    van der Heijde, D.
    Landewe, R.
    Florentinus, S.
    Arulmani, U.
    Liu, S.
    Kupper, H.
    Kavanaugh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 227 - 228
  • [7] Initial Combination Therapy with Adalimumab Plus Methotrexate Leads to Better Long-Term Outcomes in Patients with Advanced Rheumatoid Arthritis: Analysis of the Final 10-Year Results of An Open-Label Extension of a Phase 3 Trial.
    Keystone, Edward
    van der Heijde, Desiree
    Weinblatt, Michael E.
    Mozaffarian, Neelufar
    Guerette, Benoit
    Kupper, Hartmut
    Liu, Shufang
    Wolfe, Benjamin
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S870 - S871
  • [8] Initial Combination Therapy with Adalimumab Plus Methotrexate Leads to Better Long-Term Outcomes Than with Either Monotherapy in Patients with Early Rheumatoid Arthritis: 8-Year Results of An Open-Label Extension of a Phase 3 Trial
    Breedveld, Ferdinand C.
    Keystone, Edward
    van der Heijde, Desiree
    Landewe, Robert
    Smolen, Josef
    Guerette, Benoit
    McIlraith, Melissa
    Kupper, Hartmut
    Liu, Shufang
    Wolfe, Benjamin
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S481 - S481
  • [9] INITIAL COMBINATION THERAPY WITH ADALIMUMAB PLUS METHOTREXATE LEADS TO BETTER LONG-TERM OUTCOMES THAN WITH EITHER MONOTHERAPY IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: 8-YEAR RESULTS OF AN OPEN-LABEL EXTENSION OF A PHASE 3 TRIAL
    Breedveld, Ferdinand
    Keystone, Edward
    van der Heijde, Desiree
    Landewe, Robert
    Smolen, Josef S.
    Guerette, Benoit
    McIlraith, Melissa
    Kupper, Hartmut
    Liu, Shufang
    Kavanaugh, Arthur
    RHEUMATOLOGY, 2012, 51 : 118 - 119
  • [10] INITIAL COMBINATION THERAPY WITH ADALIMUMAB PLUS METHOTREXATE LEADS TO BETTER LONG-TERM OUTCOMES IN PATIENTS WITH ADVANCED RHEUMATOID ARTHRITIS: ANALYSIS OF THE FINAL 10-YEAR RESULTS OF AN OPEN-LABEL EXTENSION OF A PHASE 3 TRAIL
    Keystone, Edward C.
    van der Heijde, Desiree
    Weinblatt, Michael E.
    Mozaffarian, Neelufar
    Guerette, Benoit
    Kupper, Hartmut
    Liu, Shufang
    Kavanaugh, Arthur
    RHEUMATOLOGY, 2012, 51 : 115 - 115
12345